Using Biomarkers to Assess the Risk of Comorbidities in Psoriasis | Catherine Smith, MD | UK

Biomarkers for practical use in 2021| Catherine Smith, MD | UKПодробнее

GWU TSLS 10/20/16 - Dr. Qureshi - Part 3Подробнее

Introduction: Personalized medicine in psoriasis with a focus on stratification and biomarkersПодробнее

Update on BSTOP study and the launch of MySkin - Professor Catherine Smith and Dr Satveer MahilПодробнее

Biomarkers in the Long-term Management of Psoriasis | Catherine Smith, MD | United KingdomПодробнее

Biomarkers in Psoriasis Treatment - Today and in the Future | Lone Skov, MD, PhD | DenmarkПодробнее

Using Biomarkers to Assess the Risk of Comorbidities in Atopic Dermatitis | Christian VestergaardПодробнее

Psoriasis Treatment Pathways with Professor Catherine SmithПодробнее

Sweet and Sour (Ep 40: Biomarkers in inflammatory skin diseases: Kilian Eyerich, Catherine Smith)Подробнее

COVID-19, psoriasis and future research opportunities - Professor Catherine SmithПодробнее

Using Biomarkers to Determine Medicines’ EffectivenessПодробнее

Understanding psoriasis genetics and implications for patient management, Catherine SmithПодробнее

Dr. Chip Petricoin on Using Biomarkers for ScreeningПодробнее

'Pso: Let's Talk Research' WebinarПодробнее

Comorbidities Associated with PsoriasisПодробнее

Psoriatic ArthritisПодробнее

Anna Barker - The Next Challenge in Precision Cancer Medicine: Evolutionary Cancer BiomarkersПодробнее

Comorbidity in Psoriasis: how to handle?Подробнее